Basket

0579339 - ÚMCH 2025 RIV NL eng J - Journal Article
Möckel, D. - Bartneck, M. - Niemietz, P. - Wagner, M. - Ehling, J. - Rama, E. - Weiler, M. - Gremse, F. - Eulberg, D. - Pola, Robert - Pechar, Michal - Etrych, Tomáš - Storm, G. - Kiessling, F. - Tacke, F. - Lammers, T.
CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy.
Journal of Controlled Release. Roč. 365, January (2024), s. 358-368. ISSN 0168-3659. E-ISSN 1873-4995
R&D Projects: GA MZd(CZ) NU21-08-00280
Institutional support: RVO:61389013
Keywords : chemokine signaling * CCL2 * tumor targeting
OECD category: Polymer science
Impact factor: 10.8, year: 2022
Method of publishing: Limited access
https://www.sciencedirect.com/science/article/pii/S0168365923007617?via%3Dihub
Permanent Link: https://hdl.handle.net/11104/0348181